Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM171A1 antisense RNA 1 (FAM171A1-AS1) is a long non-coding RNA transcribed antisense to the FAM171A1 protein-coding gene. While specific studies on FAM171A1-AS1 are sparse, antisense lncRNAs typically function in regulating the expression of adjacent or overlapping protein-coding genes—often affecting mRNA stability, splicing, nuclear export, or translation. Many antisense lncRNAs have been implicated in cancer development, acting either to promote or inhibit tumor proliferation, migration, and cell death. However, no direct functional, disease, or therapeutic data is published for FAM171A1-AS1 at this time, and it is not considered a validated therapeutic target[4][5]. If you meant a gene similar to FAM83A-AS1 (a well-studied lncRNA in cancer), ensure the target name is correct. The information here is aligned with search results which confirm the existence and nomenclature for FAM171A1-AS1, but do not support drug targeting or direct disease links at present.
Not applicable, as no therapeutic agents are described for this lncRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM171A1 antisense RNA 1 (FAM171A1-AS1).